Curis Lifesciences Limited (NSE:CURIS)
India · Delayed Price · Currency is INR 179.65
-4.15 (-2.26%)
At close: Nov 9, 2026
Curis Lifesciences Revenue
In the fiscal year ending March 31, 2026, Curis Lifesciences had annual revenue of 606.29M INR with 20.63% growth. Curis Lifesciences had revenue of 127.24M in the quarter ending March 31, 2025. That makes Curis Lifesciences the 39,135th largest company in the world by revenue and 3,648th in India.
Revenue
606.29M
Revenue Growth
+20.63%
P/S Ratio
2.40
Revenue / Employee
7.05M
Employees
86
Market Cap
1.45B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 606.29M | 103.70M | 20.63% |
| Mar 31, 2025 | 502.59M | 147.03M | 41.35% |
| Mar 31, 2024 | 355.56M | 1.07M | 0.30% |
| Mar 31, 2023 | 354.49M | 117.04M | 49.29% |
| Mar 31, 2022 | 237.45M | 24.85M | 11.69% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| AVP Infracon | 4.87B |
| M. K. Proteins | 3.83B |
| Smarten Power Systems | 3.31B |
| M Tek Copper | 2.68B |
| S D Retail | 2.08B |
| Canarys Automations | 1.98B |
| De Neers Tools | 1.78B |
| Esprit Stones | 1.73B |